Metformin as a Potential Neuroprotective Agent in Prodromal Parkinson's Disease—Viewpoint
出版年份 2020 全文链接
标题
Metformin as a Potential Neuroprotective Agent in Prodromal Parkinson's Disease—Viewpoint
作者
关键词
-
出版物
Frontiers in Neurology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-06-12
DOI
10.3389/fneur.2020.00556
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Metformin protects rotenone-induced dopaminergic neurodegeneration by reducing lipid peroxidation
- (2020) Gul Ozbey et al. Pharmacological Reports
- Semaglutide is Neuroprotective and Reduces α-Synuclein Levels in the Chronic MPTP Mouse Model of Parkinson’s Disease
- (2019) Liping Zhang et al. Journal of Parkinsons Disease
- Evolution of prodromal Parkinson’s disease and dementia with Lewy bodies: a prospective study
- (2019) Seyed-Mohammad Fereshtehnejad et al. BRAIN
- Dysfunction of Cellular Proteostasis in Parkinson’s Disease
- (2019) Šárka Lehtonen et al. Frontiers in Neuroscience
- Effect of metformin on neurodegenerative disease among elderly adult US veterans with type 2 diabetes mellitus
- (2019) Qian Shi et al. BMJ Open
- AMPK promotes induction of the tumor suppressor FLCN through activation of TFEB independently of mTOR
- (2019) Caterina Collodet et al. FASEB JOURNAL
- Update of the MDS research criteria for prodromal Parkinson's disease
- (2019) Sebastian Heinzel et al. MOVEMENT DISORDERS
- Focused ultrasound in Parkinson's disease: A twofold path toward disease modification
- (2019) Guglielmo Foffani et al. MOVEMENT DISORDERS
- Analysis of the Relationship between Type II Diabetes Mellitus and Parkinson’s Disease: A Systematic Review
- (2019) Fauze Camargo Maluf et al. Parkinsons Disease
- Metformin ameliorates stress-induced depression-like behaviors via enhancing the expression of BDNF by activating AMPK/CREB-mediated histone acetylation
- (2019) Wenting Fang et al. JOURNAL OF AFFECTIVE DISORDERS
- Neuroprotection in Parkinson’s disease: facts and hopes
- (2019) András Salamon et al. JOURNAL OF NEURAL TRANSMISSION
- Neuroprotective effect of metformin on dopaminergic neurodegeneration and α-synuclein aggregation in C. elegans model of Parkinson’s disease
- (2019) Nada Saewanee et al. NEUROSCIENCE RESEARCH
- Diabetes mellitus and Parkinson disease
- (2018) Gennaro Pagano et al. NEUROLOGY
- Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease
- (2018) Xian-Si Zeng et al. Frontiers in Aging Neuroscience
- The Parkinson Pandemic—A Call to Action
- (2018) E. Ray Dorsey et al. JAMA Neurology
- The Therapeutic Potential of Metformin in Neurodegenerative Diseases
- (2018) Carola Rotermund et al. Frontiers in Endocrinology
- Long-Term Metformin Usage and Cognitive Function among Older Adults with Diabetes
- (2018) Tze Pin Ng et al. JOURNAL OF ALZHEIMERS DISEASE
- Metformin Use Associated with Reduced Risk of Dementia in Patients with Diabetes: A Systematic Review and Meta-Analysis
- (2018) Jared M. Campbell et al. JOURNAL OF ALZHEIMERS DISEASE
- Evaluation of Metformin on Cognitive Improvement in Patients With Non-dementia Vascular Cognitive Impairment and Abnormal Glucose Metabolism
- (2018) Yufeng Lin et al. Frontiers in Aging Neuroscience
- Mitochondrial dysfunction and increased glycolysis in prodromal and early Parkinson's blood cells
- (2018) Amy M. Smith et al. MOVEMENT DISORDERS
- Earlier onset of motor complications in Parkinson's patients with comorbid diabetes mellitus
- (2018) Norlinah Mohamed Ibrahim et al. MOVEMENT DISORDERS
- Metformin restores the mitochondrial network and reverses mitochondrial dysfunction in Down syndrome cells
- (2017) Antonella Izzo et al. HUMAN MOLECULAR GENETICS
- Neuroprotective Surgical Strategies in Parkinson’s Disease: Role of Preclinical Data
- (2017) Napoleon Torres et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Influence of diabetes mellitus on longitudinal atrophy and cognition in Parkinson's disease
- (2017) Marissa Ong et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
- (2017) Dilan Athauda et al. LANCET
- Therapeutic potential of autophagy-enhancing agents in Parkinson’s disease
- (2017) Tim E. Moors et al. Molecular Neurodegeneration
- Glitazone use associated with reduced risk of Parkinson's disease
- (2017) Brage Brakedal et al. MOVEMENT DISORDERS
- Parkinson disease: Exenatide – a drug for diabetes and Parkinson disease?
- (2017) Joseph Jankovic Nature Reviews Neurology
- Metformin lowers α-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson's disease
- (2017) Nikita Katila et al. NEUROPHARMACOLOGY
- Activation of the ATF2/CREB-PGC-1α pathway by metformin leads to dopaminergic neuroprotection
- (2017) Hojin Kang et al. Oncotarget
- Hyposmia Is Associated with RBD for PD Patients with Variants of SNCA
- (2017) Yuanyuan Li et al. Frontiers in Aging Neuroscience
- Is Exenatide a Treatment for Parkinson’s Disease?
- (2017) Dilan Athauda et al. Journal of Parkinsons Disease
- Parkinson disease
- (2017) Werner Poewe et al. Nature Reviews Disease Primers
- Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments
- (2017) Panchanan Maiti et al. Translational Neurodegeneration
- Diabetes, Gray Matter Loss, and Cognition in the Setting of Parkinson Disease
- (2016) M. Petrou et al. ACADEMIC RADIOLOGY
- Metformin is not just an antihyperglycaemic drug but also has protective effects on the vascular endothelium
- (2016) C. R. Triggle et al. Acta Physiologica
- Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease
- (2016) Henrik H Hansen et al. BRAIN RESEARCH
- Metformin Activates AMPK through the Lysosomal Pathway
- (2016) Chen-Song Zhang et al. Cell Metabolism
- Metformin as a Tool to Target Aging
- (2016) Nir Barzilai et al. Cell Metabolism
- Metformin Suppresses Diabetes-Accelerated Atherosclerosis via the Inhibition of Drp1-Mediated Mitochondrial Fission
- (2016) Qilong Wang et al. DIABETES
- Potential effects of current drug therapies on cognitive impairment in patients with type 2 diabetes
- (2016) Caterina Palleria et al. FRONTIERS IN NEUROENDOCRINOLOGY
- AMPK governs lineage specification through Tfeb-dependent regulation of lysosomes
- (2016) Nathan P. Young et al. GENES & DEVELOPMENT
- Neuroprotective and Therapeutic Strategies against Parkinson’s Disease: Recent Perspectives
- (2016) Sumit Sarkar et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Metformin Prevents Dopaminergic Neuron Death in MPTP/P-Induced Mouse Model of Parkinson’s Disease via Autophagy and Mitochondrial ROS Clearance
- (2016) Ming Lu et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Parkinson’s: a syndrome rather than a disease?
- (2016) Nataliya Titova et al. JOURNAL OF NEURAL TRANSMISSION
- Novel incretin analogues improve autophagy and protect from mitochondrial stress induced by rotenone in SH-SY5Y cells
- (2016) Jaishree Jalewa et al. JOURNAL OF NEUROCHEMISTRY
- Mitochondrial dysfunction in Parkinson's disease
- (2016) Anindita Bose et al. JOURNAL OF NEUROCHEMISTRY
- Genetics of Parkinson's disease
- (2016) Christina M. Lill MOLECULAR AND CELLULAR PROBES
- Pioglitazone ameliorates the phenotype of a novel Parkinson’s disease mouse model by reducing neuroinflammation
- (2016) Milena Pinto et al. Molecular Neurodegeneration
- Unravelling the nonmotor mysteries of Parkinson disease
- (2016) K. Ray Chaudhuri et al. Nature Reviews Neurology
- A novel dual GLP-1 and GIP incretin receptor agonist is neuroprotective in a mouse model of Parkinson’s disease by reducing chronic inflammation in the brain
- (2016) Lijun Cao et al. NEUROREPORT
- Cross-talk between amyloidogenic proteins in type-2 diabetes and Parkinson’s disease
- (2016) Istvan Horvath et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: A multicenter study
- (2015) Ronald B. Postuma et al. ANNALS OF NEUROLOGY
- AMPK activation protects from neuronal dysfunction and vulnerability across nematode, cellular and mouse models of Huntington's disease
- (2015) Rafael P. Vázquez-Manrique et al. HUMAN MOLECULAR GENETICS
- Parkinson's disease
- (2015) Lorraine V Kalia et al. LANCET
- Prediagnostic presentations of Parkinson's disease in primary care: a case-control study
- (2015) Anette Schrag et al. LANCET NEUROLOGY
- Metformin improves anxiety-like behaviors through AMPK-dependent regulation of autophagy following transient forebrain ischemia
- (2015) Alireza Sarkaki et al. METABOLIC BRAIN DISEASE
- Disease-modifying strategies for Parkinson's disease
- (2015) Lorraine V. Kalia et al. MOVEMENT DISORDERS
- MDS clinical diagnostic criteria for Parkinson's disease
- (2015) Ronald B. Postuma et al. MOVEMENT DISORDERS
- MDS research criteria for prodromal Parkinson's disease
- (2015) Daniela Berg et al. MOVEMENT DISORDERS
- Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats
- (2015) A.A. Martinez et al. NEUROBIOLOGY OF DISEASE
- Parkinson risk in idiopathic REM sleep behavior disorder: Preparing for neuroprotective trials
- (2015) R. B. Postuma et al. NEUROLOGY
- Olfactory dysfunction predicts early transition to a Lewy body disease in idiopathic RBD
- (2015) P. Mahlknecht et al. NEUROLOGY
- Neuroprotective effects of 5-(4-hydroxy-3-dimethoxybenzylidene)-thiazolidinone in MPTP induced Parkinsonism model in mice
- (2015) Zhili Ren et al. NEUROPHARMACOLOGY
- Low alpha-synuclein levels in the blood are associated with insulin resistance
- (2015) Gerardo Rodriguez-Araujo et al. Scientific Reports
- The Concept of Prodromal Parkinson’s Disease
- (2015) Philipp Mahlknecht et al. Journal of Parkinsons Disease
- Neuroprotective effects of peroxisome proliferator-activated receptor alpha and gamma agonists in model of parkinsonism induced by intranigral 1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine
- (2014) Janaína K. Barbiero et al. BEHAVIOURAL BRAIN RESEARCH
- Acute metformin preconditioning confers neuroprotection against focal cerebral ischaemia by pre-activation of AMPK-dependent autophagy
- (2014) Teng Jiang et al. BRITISH JOURNAL OF PHARMACOLOGY
- Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls
- (2014) C. A. Bannister et al. DIABETES OBESITY & METABOLISM
- Recent Advances in Drug Repositioning for the Discovery of New Anticancer Drugs
- (2014) Joong Sup Shim et al. International Journal of Biological Sciences
- Type 2 Diabetes and Antidiabetic Medications in Relation to Dementia Diagnosis
- (2014) Chin Cheng et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Pre-treatment with metformin activates Nrf2 antioxidant pathways and inhibits inflammatory responses through induction of AMPK after transient global cerebral ischemia
- (2014) Ghorbangol Ashabi et al. METABOLIC BRAIN DISEASE
- Activation of AMP-activated protein kinase by metformin protects against global cerebral ischemia in male rats: Interference of AMPK/PGC-1α pathway
- (2014) Ghorbangol Ashabi et al. METABOLIC BRAIN DISEASE
- The ongoing pursuit of neuroprotective therapies in Parkinson disease
- (2014) Dilan Athauda et al. Nature Reviews Neurology
- Neuroprotective effect of metformin in MPTP-induced Parkinson’s disease in mice
- (2014) S.P. Patil et al. NEUROSCIENCE
- Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease
- (2014) Nicolaas I. Bohnen et al. PARKINSONISM & RELATED DISORDERS
- Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide
- (2014) Krzysztof Łabuzek et al. Pharmacological Reports
- Metformin promotes lifespan through mitohormesis via the peroxiredoxin PRDX-2
- (2014) W. De Haes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metformin lowers Ser-129 phosphorylated α-synuclein levels via mTOR-dependent protein phosphatase 2A activation
- (2014) B I Pérez-Revuelta et al. Cell Death & Disease
- PINK1 deficiency in -cells increases basal insulin secretion and improves glucose tolerance in mice
- (2014) E. Deas et al. Open Biology
- Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease
- (2013) Jeffrey H. Kordower et al. BRAIN
- Metformin Retards Aging in C. elegans by Altering Microbial Folate and Methionine Metabolism
- (2013) Filipe Cabreiro et al. CELL
- Metformin revisited: A critical review of the benefit–risk balance in at-risk patients with type 2 diabetes
- (2013) A.J. Scheen et al. DIABETES & METABOLISM
- Metabolic inflammation exacerbates dopaminergic neuronal degeneration in response to acute MPTP challenge in type 2 diabetes mice
- (2013) Ling Wang et al. EXPERIMENTAL NEUROLOGY
- Exenatide and the treatment of patients with Parkinson’s disease
- (2013) Iciar Aviles-Olmos et al. JOURNAL OF CLINICAL INVESTIGATION
- Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study
- (2013) Alex Iranzo et al. LANCET NEUROLOGY
- ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase
- (2013) Ryan C. Russell et al. NATURE CELL BIOLOGY
- Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series
- (2013) Carlos H. Schenck et al. SLEEP MEDICINE
- Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy—a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group
- (2013) C.H. Schenck et al. SLEEP MEDICINE
- Metformin: an old but still the best treatment for type 2 diabetes
- (2013) Lilian Beatriz Aguayo Rojas et al. Diabetology & Metabolic Syndrome
- The Role of Autophagy in Parkinson's Disease
- (2013) M. A. Lynch-Day et al. Cold Spring Harbor Perspectives in Medicine
- Parkinson's disease, insulin resistance and novel agents of neuroprotection
- (2012) Iciar Aviles-Olmos et al. BRAIN
- Metformin Activates an Atypical PKC-CBP Pathway to Promote Neurogenesis and Enhance Spatial Memory Formation
- (2012) Jing Wang et al. Cell Stem Cell
- AMP Kinase Activation Mitigates Dopaminergic Dysfunction and Mitochondrial Abnormalities in Drosophila Models of Parkinson's Disease
- (2012) C.-H. Ng et al. JOURNAL OF NEUROSCIENCE
- The Lewy Body in Parkinson’s Disease and Related Neurodegenerative Disorders
- (2012) Koichi Wakabayashi et al. MOLECULAR NEUROBIOLOGY
- The significance of defining preclinical or prodromal Parkinson's disease
- (2012) C. Warren Olanow et al. MOVEMENT DISORDERS
- Hippocampal abnormalities and memory deficits in Parkinson disease: A multimodal imaging study
- (2012) G. A. Carlesimo et al. NEUROLOGY
- Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort
- (2012) Mark L. Wahlqvist et al. PARKINSONISM & RELATED DISORDERS
- Age- and diet-dependent requirement of DJ-1 for glucose homeostasis in mice with implications for human type 2 diabetes
- (2012) Deepak Jain et al. Journal of Molecular Cell Biology
- Metformin slows down aging and extends life span of female SHR mice
- (2011) Vladimir N. Anisimov et al. CELL CYCLE
- Metformin extends life span of HER-2/neu transgenic mice and in combination with melatonin inhibits growth of transplantable tumors in vivo
- (2011) Vladimir N. Anisimov et al. CELL CYCLE
- Transgenic expression and activation of PGC-1α protect dopaminergic neurons in the MPTP mouse model of Parkinson’s disease
- (2011) Giuseppa Mudò et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Diabetes and Risk of Parkinson's Disease: A systematic review and meta-analysis
- (2011) E. Cereda et al. DIABETES CARE
- Insulin resistance impairs nigrostriatal dopamine function
- (2011) J.K. Morris et al. EXPERIMENTAL NEUROLOGY
- Role of serotonergic 1A receptor dysfunction in depression associated with Parkinson's disease
- (2011) Benedicte Ballanger et al. MOVEMENT DISORDERS
- Why have we failed to achieve neuroprotection in Parkinson's disease?
- (2010) C. Warren Olanow et al. ANNALS OF NEUROLOGY
- Lactic Acidosis Induced by Metformin
- (2010) Jean-Daniel Lalau DRUG SAFETY
- CREB: a multifaceted regulator of neuronal plasticity and protection
- (2010) Kensuke Sakamoto et al. JOURNAL OF NEUROCHEMISTRY
- Missing pieces in the Parkinson's disease puzzle
- (2010) Jose A Obeso et al. NATURE MEDICINE
- PGC-1 , A Potential Therapeutic Target for Early Intervention in Parkinson's Disease
- (2010) B. Zheng et al. Science Translational Medicine
- AMP-activated protein kinase is activated in Parkinson’s disease models mediated by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
- (2009) Jae-Sun Choi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Etiology and Pathogenesis of Parkinson Disease
- (2009) Anthony H.V. Schapira NEUROLOGIC CLINICS
- Dopamine-induced proliferation of adult neural precursor cells in the mammalian subventricular zone is mediated through EGF
- (2009) G. C. O'Keeffe et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glucagon-like peptide 1 receptor stimulation by exendin-4 reverses key deficits in distinct rodent models of Parkinson's disease
- (2008) Alexander Harkavyi et al. Journal of Neuroinflammation
- Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder
- (2008) R. B. Postuma et al. NEUROLOGY
- Selective hyposmia in Parkinson disease: Association with hippocampal dopamine activity
- (2008) Nicolaas I. Bohnen et al. NEUROSCIENCE LETTERS
- Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of parkinson's disease
- (2007) Göran Bertilsson et al. JOURNAL OF NEUROSCIENCE RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started